“No swift action” on US CBD regulation after FDA comments, warns analyst
CBD beverage producers in the US may have to wait for clarity on regulation as authorities look set to miss a February deadline, an analyst has said.
CBD beverage producers in the US may have to wait for clarity on regulation as authorities look set to miss a February deadline, an analyst has said.